Dimensional Fund Advisors’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-600
Closed -$8K 3590
2013
Q3
$8K Hold
600
﹤0.01% 3539
2013
Q2
$9K Buy
+600
New +$8.74K ﹤0.01% 3535

Dimensional Fund Advisors's OPTR Position: Q4 2013 in Review

Dimensional Fund Advisors sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 600 shares — an estimated $8K sold.

Dimensional Fund Advisors first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $9K in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Dimensional Fund Advisors reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Dimensional Fund Advisors sold 600 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $8K.
  • Dimensional Fund Advisors first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Dimensional Fund Advisors's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $9K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Dimensional Fund Advisors's 13F filing for Q4 2013, filed 12 Feb 2014.